CancerVax Opens New Facilty, Cleanrooms

June 1, 2001 — CARLSBAD, CA — Biotech development company CancerVax Corporation has completed construction of its new biologics manufacturing facility located outside of Los Angeles.

The 26,000 square foot facility contains more than 10,000 square feet of cleanroom space that will be used as production suites for vaccine manufacturing. CancerVax specializes in immunotherapeutic products for the treatment of cancer.

“This new facility is an important step toward the commercialization of our vaccine product,” said David F. Hale, president and CEO of CancerVax.

Hale also said the new facility will allow the company to produce therapeutic vaccine in two ongoing Phase 3 clinical trials for melanoma and allow the company to initiate clinical testing for other cancers. In addition, the facility is expected to provide scalable production for commercial sales.

POST A COMMENT

Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.